首页> Journal of medical virology> Real-world evaluation of the impact of two anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults.

Real-world evaluation of the impact of two anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults.

导出 OA

翻译打印收藏纠错

第一作者： Kristine A,Sobolewski

第一单位： Pharmacy Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA.

作者： Kristine A,Sobolewski ^[1] ; Steven M,Smoke ^[1] ; Alison,Brophy ^[1] ; Andrew V,Vassallo ^[2] ; Brandon,Chen ^[3] ; Patrick,Hilden ^[4] ; Rebecca,Patterson ^[2] ; Marina,Pittiglio ^[2] ; Karan,Raja ^[3] ; Eric,Handler ^[5] ; Christopher,Freer ^[6]

作者单位： Pharmacy Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA. ^[1] Department of Pharmacy, Community Medical Center, Toms River, New Jersey, USA. ^[2] Pharmacy Department, Clara Maass Medical Center, Belleville, New Jersey, USA. ^[3] Biostatistics Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA. ^[4] Emergency Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA. ^[5] Emergency and Hospitalist Medicine Service Line, RWJBarnabas Health, West Orange, New Jersey, USA. ^[6]

关键词 COVID-19 anti-SARS-CoV-2 monoclonal antibodies bamlanivimab casirivimab?+?imdevimab older adults

医学主题词老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗体, 病毒(Antibodies, Viral);队列研究(Cohort Studies);住院(Hospitalization);人类(Humans);回顾性研究(Retrospective Studies)

DOI 10.1002/jmv.27668

PMID 35199356

发布时间 2024-08-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交